Skip to main content
SpringerLink
Log in

Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication

  • LETTER TO THE EDITORS
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS) and Kendle, PO Box 80.082, 3508 TB Utrecht, The Netherlands e-mail: claessens.angela@kendle.com Tel.: +31-30-2537324; Fax: +31-30-2539166, , , , , , NL

    A. A. M.C. Claessens, E. R. Heerdink & H. G. M. Leufkens

  2. Department of Medical Sociology, Health Care Studies, Faculty of Medicine, University of Maastricht, Maastricht, The Netherlands, , , , , , NL

    J. T. M. van Eijk

  3. Department of Gastroenterology, Leiden University, Leiden, The Netherlands, , , , , , NL

    C. B. H. W. Lamers

Authors
  1. A. A. M.C. Claessens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. R. Heerdink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. T. M. van Eijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. B. H. W. Lamers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. G. M. Leufkens
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 27 July 1999 / Accepted in revised form: 27 October 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Claessens, A., Heerdink, E., van Eijk, J. et al. Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication. E J Clin Pharmacol 55, 773–776 (2000). https://doi.org/10.1007/s002280050013

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050013

Keywords

Search

Navigation